The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Kruppel-like factor 2 (KLF2) has been implicated in the regulation of cell proliferation, differentiation, and survival in a variety of cells. Recently, it has been reported that KLF2 regulates the p65-mediated transactivation of NF-B. Although the NF-B pathway plays an important role in the differentiation of osteoclasts and osteoblasts, the role of KLF2 in these bone cells has not yet been fully elucidated. In this study, we demonstrated that KLF2 regulates osteoclast and osteoblast differentiation. The overexpression of KLF2 in osteoclast precursor cells inhibited osteoclast differentiation by downregulating c-Fos, NFATc1, and TRAP expression, while KLF2 overexpression in osteoblasts enhanced osteoblast differentiation and function by upregulating Runx2, ALP, and BSP expression. Conversely, the downregulation of KLF2 with KLF2-specific siRNA increased osteoclast differentiation and inhibited osteoblast differentiation. Moreover, the overexpression of interferon regulatory protein 2-binding protein 2 (IRF2BP2), a regulator of KLF2, suppressed osteoclast differentiation and enhanced osteoblast differentiation and function. These effects were reversed by downregulating KLF2. Collectively, our data provide new insights and evidence to suggest that the IRF2BP2/KLF2 axis mediates osteoclast and osteoblast differentiation, thereby affecting bone homeostasis.
Abstract
Kruppel-like factor 2 (KLF2) has been implicated in the regulation of cell proliferation, differentiation, and survival in a variety of cells. Recently, it has been reported that KLF2 regulates the p65-mediated transactivation of NF-B. Although the NF-B pathway plays an important role in the differentiation of osteoclasts and osteoblasts, the role of KLF2 in these bone cells has not yet been fully elucidated. In this study, we demonstrated that KLF2 regulates osteoclast and osteoblast differentiation. The overexpression of KLF2 in osteoclast precursor cells inhibited osteoclast differentiation by downregulating c-Fos, NFATc1, and TRAP expression, while KLF2 overexpression in osteoblasts enhanced osteoblast differentiation and function by upregulating Runx2, ALP, and BSP expression. Conversely, the downregulation of KLF2 with KLF2-specific siRNA increased osteoclast differentiation and inhibited osteoblast differentiation. Moreover, the overexpression of interferon regulatory protein 2-binding protein 2 (IRF2BP2), a regulator of KLF2, suppressed osteoclast differentiation and enhanced osteoblast differentiation and function. These effects were reversed by downregulating KLF2. Collectively, our data provide new insights and evidence to suggest that the IRF2BP2/KLF2 axis mediates osteoclast and osteoblast differentiation, thereby affecting bone homeostasis.
참고문헌 (29)
- Leibbrandt A, "RANK", RANKL : regulators of immune responses and bone physiology, 2008, pp.1143, 123~150
- 김정하, "Signaling Pathways in Osteoclast Differentiation", 전남의대학술지, 52(1), pp.12~17 (2016), 의과학연구소
- Takayanagi H, "Induction and activation of the transcription factor NFATc1(NFAT2)integrate RANKL signaling in terminal differentiation of osteoclasts", Dev Cell, 3, pp.889~901 (2002)
- Katagiri T, "Regulatory mechanisms of osteoblast and osteoclast differentiation", Oral Dis, 8, pp.147~159 (2002)
- Matsubara T, "BMP2regulates Osterix through Msx2 and Runx2 during osteoblast differentiation", J Biol Chem, 283, pp.29119~29125 (2008)
- Schroeder TM, "Runx2 : a master organizer of gene transcription in developing and maturing osteoblasts", Birth Defects Res C Embryo Today, 75, pp.213~225 (2005)
- Boyce BF, "Functions of nuclear factor kappaB in bone", Ann N Y Acad Sci, 1192, pp.367~375 (2010)
- 김인영, "Tusc2", Fus1 regulates osteoclast differentiation through NF-kB and NFATc1, 2017, pp.50(9), 454~459[DOI]
- 박선욱, "Heme oxygenase-1 (HO-1)", carbon monoxide (CO) axis suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF-κB activation, 2017, pp.50(2), 103~108[DOI]
- Yamashita T, "NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand(RANKL)and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1", J Biol Chem, 282, pp.18245~18253 (2007)
- Yamazaki M, "Tumor necrosis factor alpha represses bone morphogenetic protein(BMP)signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB", J Biol Chem, 284, pp.35987~35995 (2009)
- Yao Z, "NF-kappaB RelB negatively regulates osteoblast differentiation and bone formation", J Bone Miner Res, 29, pp.866~877 (2014)
- Lee J, "Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation", J Bone Miner Res, 30, pp.1597~1607 (2015)
- Nayak L, "Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation", Am J Pathol, 182, pp.1696~1704 (2013)
- Dang DT, "The biology of the mammalian Kruppel-like family of transcription factors", Int J Biochem Cell Biol, 32, pp.1103~1121 (2000)
- Das H, "Kruppel-like factor 2(KLF2)regulates proinflammatory activation of monocytes", Proc Natl Acad Sci U S A, 103, pp.6653~6658 (2006)
- Das M, "Kruppel-like factor 2(KLF2)regulates monocyte differentiation and functions in mBSA and IL-1beta-induced arthritis", Curr Mol Med, 12, pp.113~125 (2012)
- Childs KS, "Identification of novel co-repressor molecules for Interferon Regulatory Factor-2", Nucleic Acids Res, 31, pp.3016~3026 (2003)
- Carneiro FR, "Interferon regulatory factor 2 binding protein 2is a new NFAT1 partner and represses its transcriptional activity", Mol Cell Biol, 31, pp.2889~2901 (2011)
- Teng AC, "IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression", FASEB J, 24, pp.4825~4834 (2010)
- Chen HH, "IRF2BP2Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis", Circ Res, 117, pp.671~683 (2015)
- Jha P, "KLF2 in Regulation of NF-kappaB-Mediated Immune Cell Function and Inflammation", Int J Mol Sci, 18, pp.2383~2420 (2017)
- SenBanerjee S, "KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation", J Exp Med, 199, pp.1305~1315 (2004)
- Brendan F. Boyce, "NF-κB-Mediated Regulation of Osteoclastogenesis", Endocrinology and Metabolism, 30(1), pp.35~44 (2015), 대한내분비학회
- Chang J, "Inhibition of osteoblastic bone formation by nuclear factor-kappaB", Nat Med, 15, pp.682~689 (2009)
- Cao Z, "Role of Kruppel-like factors in leukocyte development, function, and disease", Blood, 116, pp.4404~4414 (2010)
- Zhang H, "IRF2BP2 : A New Player at the Crossroads of Inflammation and Lipid Metabolism", Circ Res, 117, pp.656~658 (2015)
- Zhou B, "Regulation of the murine Nfatc1 gene by NFATc2", J Biol Chem, 277, pp.10704~10711 (2002)
- Ikeda F, "Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation", J Clin Invest, 114, pp.475~484 (2004)